Cytotoxicity of three Orchid species extracts against HeLa, MCF-7, and T47D cancer cells
DOI:
https://doi.org/10.22437/proca.v1i2.50530Keywords:
Orchid, Cytotoxicity; MTT Assay; MCF-7, Dendrobium crumenatumAbstract
Background: Cancer remains a leading cause of death globally, necessitating the search for novel therapeutic agents from natural sources. Orchids, known to produce diverse secondary metabolites, hold significant potential. Objective: This study aims to evaluate and quantitatively compare the in vitro cytotoxicity activity of crude methanol extracts from three orchid species against HeLa, MCF-7, and T47D cells using the MTT assay. Methods: This study investigated the comparative in vitro cytotoxic activity of crude methanol extracts from three native orchid species, Cymbidium sp., Grammatophyllum speciosum, and Dendrobium crumenatum, against three human cancer cell lines: HeLa (cervical), MCF-7 (breast), and T47D (breast). Cytotoxicity assessment was performed using the MTT Assay. The extracts were tested at various concentrations to determine their inhibitory concentrations IC50.Results: The results showed that the three orchid extracts exhibited varying cytotoxic effects across the tested cell lines. Significantly, the crude methanol extract of Dendrobium crumenatum showed the most promising activity, especially against MCF-7 breast cancer cells, with an IC50 value of 126.58±5.50 µg/mL. The activity against HeLa and T47D was less potent. These findings indicate that secondary metabolites in Dendrobium crumenatum have selective antiproliferative properties. Conclusion: In conclusion, the methanol extract of Dendrobium crumenatum is a potential candidate for the isolation and further identification of active compounds in developing anticancer drugs, especially for breast cancer.
Downloads
References
[1] Zafar A, Khatoon S, Khan MJ, Abu J, Naeem A. Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discov Oncol [Internet]. 2025 Apr 24 [cited 2025 Oct 28];16(1):607. Available from: https://doi.org/10.1007/s12672-025-02198-8
[2] Asma ST, Acaroz U, Imre K, Morar A, Shah SRA, Hussain SZ, et al. Natural Products/Bioactive Compounds as a Source of Anticancer Drugs. Cancers [Internet]. 2022 Jan [cited 2025 May 10];14(24):6203. Available from: https://www.mdpi.com/2072-6694/14/24/6203
[3] Tiwari P, Bose SK, Gautam A, Chen JT. Emerging trends and insights into the cultivation strategies, ethnomedicinal uses, and socio-economic attributes of orchids. J Hortic Sci Biotechnol [Internet]. 2023 May 4 [cited 2025 Oct 28];98(3):273–98. Available from: https://doi.org/10.1080/14620316.2022.2164524
[4] Li K, Wu F, Chen M, Xiao Z, Xu Y, Xu M, et al. Identification, Biological Function Profiling and Biosynthesis of Secondary Metabolites in Medicinal Orchids. Metabolites [Internet]. 2023 Jul;13(7):829. https://www.mdpi.com/2218-1989/13/7/829
[5] Husen A, Exploring Medicinal Orchids. Boca Raton: CRC Press; 2024. 162 p.
[6] Rahaman MdS, Rahaman MdS, Hasnine SMdM, Sultana S, Bhuiyan MdAQ, Kabir MS, et al. Evaluation of In Vitro Antimicrobial, Cytotoxic, Thrombolytic, and Antiarthritic Property of Different Parts of Bari Orchid. Evid Based Complement Alternat Med [Internet]. 2024 [cited 2025 Oct 28];2024(1):8148610. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1155/2024/8148610
[7] Saatci O, Huynh-Dam KT, Sahin O. Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies. J Mol Med [Internet]. 2021 Dec 1 [cited 2025 Oct 28];99(12):1691–710. Available from: https://doi.org/10.1007/s00109-021-02136-5
[8] Shi Y, Xu S, Li S. Selinexor improves the anti-cancer effect of tucidinostat on TP53 wild-type breast cancer. Mol Cell Endocrinol [Internet]. 2022 Apr 5 [cited 2025 Oct 28];545:111558. Available from: https://www.sciencedirect.com/science/article/pii/S0303720722000053
[9] Marvalim C, Datta A, Lee SC. Role of p53 in breast cancer progression: An insight into p53 targeted therapy. Theranostics [Internet]. 2023 Feb 27 [cited 2025 Oct 28];13(4):1421–42. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10008729/
[10] Gede Sudaryati NL, Utomo B, Mertha Adnyana IMD, Fauziyah S, Hari Sucipto T, Lakustini Cahyaningrum P, et al. Phytochemical profiling, dengue antiviral properties, and cytotoxicity of novel Baper tea polyherbal infusion: Insights from in silico and in vitro studies. Salud, Ciencia y Tecnología. 2025 Jun. 19;5:1791.
[11] Zasheva D, Mladenov P, Zapryanova S, Gospodinova Z, Georgieva M, Alexandar I, et al. Cytotoxic Effects of Plant Secondary Metabolites and Naturally Occurring Bioactive Peptides on Breast Cancer Model Systems: Molecular Mechanisms. Molecules [Internet]. 2024 Jan;29(22):5275. https://www.mdpi.com/1420-3049/29/22/5275
[12] Chandrasekaran P, Uddandrao VVS, Ganapathy S, Sasikumar V, Prakash B. A Comprehensive Review of Molecular Targets and Therapeutic Potential of Phytomedicine for the Treatment of Breast Cancer. In: Therapeutic Plants: Recent Advances in the Use of Herbs as Alternative Medications. Bentham Science Publishers; 2025. p. 136–87.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Syamsurizal, Diah Tri Utami, Fitrianingsih, Indri Maharini, Beni Hendro Prabowo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Published with license by LPPM Universitas Jambi. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0 International). This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator.
